Latest Insider Trading
Filed: 2026-04-23
Key Insights
- SVP of R&D David Chairman executed a net sell transaction of 400 ordinary shares on 04/22/2026, selling at $1.65 per share after exercising options at $0.86, realizing a gain of approximately $316 per share.
- The transaction was executed under a Rule 10b5-1 trading plan adopted on August 16, 2024, indicating a pre-planned, systematic approach to share liquidation rather than reactive trading.
- Post-transaction beneficial ownership decreased to 403,968 ordinary shares, suggesting the executive is moderately reducing his equity stake while retaining significant holdings in the company.
- The exercise and immediate sale pattern on the same date indicates the executive is capturing option gains without maintaining additional equity exposure beyond his existing share position.